FDA Wants Authority To Enforce Track-And-Trace System For Drugs
Executive Summary
Congress should empower FDA to enforce the track-and-trace standard for drugs that the agency already is tasked with developing, Deputy Commissioner for Global Regulatory Operations and Policy Deborah Autor told the Senate Health, Education, Labor and Pensions Committee Sept. 14.
You may also be interested in...
FDA Again Taps Compliance Director For Globalization Post
Howard Sklamberg, currently director of the CDER Office of Compliance, will take over the Office of Global Regulatory Operations and Policy after a year as CDER compliance office director.
Track-and-Trace Deal’s Failure Leaves California In Control Of Agenda
Industry groups will continue to search for legislative vehicles to move a national standard that would preempt state laws; near-term, though, manufacturers and distributors must prepare for California pedigree law.
GMP Carrots For Quality: FDA Considers Incentives To Adopt Quality Systems
The type of incentive remains under consideration, but one suggestion is a grading system similar to what restaurants receive from local health departments.